74.3
Verrica Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
39.1
FY23:
77.5
FY24:
51.2
FY25:
42.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.80
FY22:
5.61
FY23:
4.07
FY24:
2.96
FY25:
4.59
Total assets
Change from FY21 to FY25
millions USD
FY21:
80.1
FY22:
44.7
FY23:
81.6
FY24:
54.1
FY25:
47.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
46.1
FY22:
3.46
FY23:
17.0
FY24:
29.0
FY25:
16.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.47
FY22:
1.23
FY23:
44.8
FY24:
35.0
FY25:
5.95
(positive)
Change from FY21 to FY25
millions USD
FY21:
32.6
FY22:
40.0
FY23:
19.8
FY24:
−9.86
FY25:
24.7
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
80.1
FY22:
44.7
FY23:
81.6
FY24:
54.1
FY25:
47.1
All amounts in millions USD